LCI Share Price

Open 23.80 Change Price %
High 25.20 1 Day 0.60 2.54
Low 23.60 1 Week 1.55 6.84
Close 24.20 1 Month 6.15 34.07
Volume 884415 1 Year -13.25 -35.38
52 Week High 44.49
52 Week Low 16.75
LCI Important Levels
Resistance 2 25.68
Resistance 1 25.07
Pivot 24.33
Support 1 23.33
Support 2 22.72
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
CVM 0.11 -38.89%
CVM 0.11 -38.89%
PLX 0.31 -44.64%
PLX 0.31 -44.64%
RBY 0.03 -70.00%
NAK 1.45 21.85%
NAK 1.45 21.85%
More..
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
CMFO 0.12 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
IG 7.68 22.49%
More..
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
RVP 1.30 -46.94%
PLX 0.31 -44.64%
PLX 0.31 -44.64%
CVM 0.11 -38.89%
CVM 0.11 -38.89%
QBC 0.20 -33.33%
More..

Lannett Co Inc (AMEX: LCI)

LCI Technical Analysis 3
As on 2nd Dec 2016 LCI Share Price closed @ 24.20 and we RECOMMEND Sell for LONG-TERM with Stoploss of 25.57 & Sell for SHORT-TERM with Stoploss of 24.20 we also expect STOCK to react on Following IMPORTANT LEVELS.
LCI Target for December
1st Target up-side 27.31
2nd Target up-side 30.41
3rd Target up-side 33.5
1st Target down-side 18.49
2nd Target down-side 15.39
3rd Target down-side 12.3
LCI Other Details
Segment EQ
Market Capital 117666264.00
Sector Healthcare
Industry Drug Manufacturers - Other
Offical website http://www.lannett.com
LCI Address
LCI
9000 State Road
Philadelphia, PA 19136
United States
Phone: 215-333-9000
Interactive Technical Analysis Chart Lannett Co Inc ( LCI AMEX USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Lannett Co Inc
LCI Business Profile
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of branded pharmaceutical products in the United States. It offers solid oral, extended release, topical, and oral solution finished dosage forms of drugs that address a range of therapeutic areas. The company provides its products for various medical indications comprising glaucoma, migraine, antibiotic, anesthetic, endometriosis, irritable bowel syndrome, obesity, congestive heart failure, antipsychotic, pain management, thyroid deficiency, dryness of the mouth, epilepsy, gout, bronchospasms, hypertension, and gallstone. Lannett Company, Inc. markets its products under the Diamox, Fioricet, Fiorinal, Fiorinal w/ Codeine #3, Cleocin, Danocrine, Bentyl, Tenuate, Dospan, Lanoxin, Adoxa, Periostat, Prolixin, Dilaudid, Levoxyl, Synthroid, Loxitane, Adipex-P, Fastin, Salagen, Mysoline, Benemid, Rifadin, Brethine, Dyazide, and Actigall brands. It also manufactures active pharmaceutical ingredients. The company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. It has development and supply agreements with Azad Pharma AG, Swiss Caps of Switzerland, Pharma 2B, and the GC Group of Israel, as well as with Jerome Stevens Pharmaceuticals, Inc., Cerovene, and Summit Bioscience LLC. The company was founded in 1942 and is based in Philadelphia, Pennsylvania.